Prophylaxis and Treatment of Cancer-Associated Venous Thromboembolism - Comparison Hematologist/Oncologists versus Angiologist/Phlebologists

被引：0
|
作者：
Matzdorff, Axel [1 ]
Ledig, Bettina [2 ]
Stuecker, Markus [3 ]
Riess, Hanno [4 ]
机构：
[1] Asklepios Clin Uckermark, Dept Internal Med 2, Auguststr 23, D-16303 Schwedt Od, Germany
[2] LEO Pharma GmbH, Neu Isenburg, Germany
[3] Ruhr Univ Bochum, St Josef Hosp, Dept Dermatol, Bochum, Germany
[4] Charite Campus Virchow Clin, Med Clin Haematol Oncol, Berlin, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷 / 03期
关键词：
Cancer-associated venous thromboembolism; Health services research; Hematologist; Oncologist; Angiologist Phlebologist; CLINICAL-PRACTICE GUIDELINES; DEEP-VEIN THROMBOSIS; ADHERENCE; RISK;
D O I：
10.1159/000456670
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：138 / 140
页数：3
相关论文
共 50 条
  • [1] Practice patterns for prophylaxis and treatment of cancer related venous thromboembolism (VTE) in Germany: Comparison hematologists/oncologists (HOs) vs. angiologists/phlebologists (APs)
    Matzdorff, Axel
    Ledig, Bettina
    Stuecker, Markus
    Riess, Hanno
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
    Raskob, Gary E.
    van Es, Nick
    Verhamme, Peter
    Carrier, Marc
    Di Nisio, Marcello
    Garcia, David
    Grosso, Michael A.
    Kakkar, Ajay K.
    Kovacs, Michael J.
    Mercuri, Michele F.
    Meyer, Guy
    Segers, Annelise
    Shi, Minggao
    Wang, Tzu-Fei
    Yeo, Erik
    Zhang, George
    Zwicker, Jeffrey I.
    Weitz, Jeffrey I.
    Buller, Harry R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (07): : 615 - 624
  • [3] Cancer-associated venous Thromboembolism: Edoxaban versus Dalteparin
    Lorenz, Judith
    TRANSFUSIONSMEDIZIN, 2018, 8 (03) : 137 - 137
  • [4] Cancer-Associated Venous Thromboembolism
    Elewa H.
    Elrefai R.
    Barnes G.D.
    Current Treatment Options in Cardiovascular Medicine, 2016, 18 (4) : 1 - 9
  • [5] Cancer-associated venous thromboembolism
    Khorana, Alok A.
    Mackman, Nigel
    Falanga, Anna
    Pabinger, Ingrid
    Noble, Simon
    Ageno, Walter
    Moik, Florian
    Lee, Agnes Y. Y.
    NATURE REVIEWS DISEASE PRIMERS, 2022, 8 (01)
  • [6] Cancer-associated venous thromboembolism
    Alok A. Khorana
    Nigel Mackman
    Anna Falanga
    Ingrid Pabinger
    Simon Noble
    Walter Ageno
    Florian Moik
    Agnes Y. Y. Lee
    Nature Reviews Disease Primers, 8
  • [7] CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS: A COMPARATIVE EFFECTIVENESS RESEARCH
    Almohammed, O. A.
    Lai, L.
    Khanfar, N. M.
    Bleidt, B. A.
    Aljadhey, H.
    VALUE IN HEALTH, 2018, 21 : S56 - S56
  • [8] Update: Anticoagulant Treatment of Cancer-associated Venous Thromboembolism
    Riess, Hanno
    AKTUELLE KARDIOLOGIE, 2022, 11 (02) : 131 - 135
  • [9] Clinical controversies in the treatment of cancer-associated venous thromboembolism
    Nachar, Victoria R.
    Schepers, Allison J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (04) : 939 - 953
  • [10] Guidance for the prevention and treatment of cancer-associated venous thromboembolism
    Alok A. Khorana
    Marc Carrier
    David A. Garcia
    Agnes Y. Y. Lee
    Journal of Thrombosis and Thrombolysis, 2016, 41 : 81 - 91
12345